Feed NBRVF
NB
Nabriva Therapeutics plc
NBRVF · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $323.0
P/E Ratio -
Div. Yield -
ROE -
Valuation
100 /100
Cheap P/B 0.00x
P/S 0.00x
EV/FFO N/A
Growth
78 /100
Growing Book val. growth 56.95%
Rev. growth 66.35%
FCF growth N/A
Profitability
6 /100
Weak Op. margin 155.57%
Gross margin 19.87%
FCF margin 103.52%
Quality
20 /100
Poor Asset turnover 1.12x
ROIC 634.43%
ROA 180.03%
Debt
51 /100
Moderate Int. coverage -78.68x
Debt/Equity 1.59x
Net debt/EBITDA 0.13x
Stability
35 /100
Moderate EPS volatility 26.83%
Beta -0.68x
Profitable years 0
Întreabă StockBot despre NBRVF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
H. Michael Hogan
Employees
39
Headquarters
Dublin